MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 49 filers reported holding MARKER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,562 | -28.8% | 13,390 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 13,390 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -16.7% | 13,390 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -53.8% | 13,390 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -40.9% | 13,390 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | -40.5% | 13,390 | 0.0% | 0.00% | – |
| Q2 2021 | $37,000 | +23.3% | 13,390 | 0.0% | 0.00% | – |
| Q1 2021 | $30,000 | +57.9% | 13,390 | 0.0% | 0.00% | – |
| Q4 2020 | $19,000 | -9.5% | 13,390 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | -22.2% | 13,390 | 0.0% | 0.00% | – |
| Q2 2020 | $27,000 | +3.8% | 13,390 | 0.0% | 0.00% | – |
| Q1 2020 | $26,000 | -31.6% | 13,390 | 0.0% | 0.00% | – |
| Q4 2019 | $38,000 | -44.9% | 13,390 | 0.0% | 0.00% | – |
| Q3 2019 | $69,000 | -34.9% | 13,390 | 0.0% | 0.00% | – |
| Q2 2019 | $106,000 | +20.5% | 13,390 | 0.0% | 0.00% | – |
| Q1 2019 | $88,000 | – | 13,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $1,163,000 | 0.77% |
| NEA Management Company, LLC | 10,714,285 | $3,951,000 | 0.20% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $131,000 | 0.18% |
| Long Focus Capital Management, LLC | 1,461,000 | $539,000 | 0.05% |
| AR ASSET MANAGEMENT INC | 279,000 | $103,000 | 0.03% |
| MATRIX ASSET ADVISORS INC/NY | 400,000 | $148,000 | 0.02% |
| Mandatum Life Insurance Co Ltd | 99,000 | $37,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $8,000 | 0.00% |
| Riggs Asset Managment Co. Inc. | 18,500 | $7,000 | 0.00% |
| NEVILLE RODIE & SHAW INC | 60,202 | $22,000 | 0.00% |